MEETINGS - Annual EC Medical Devices Vigilance System and Postmarketing Surveillance conference (UK) January 2002:
This article was originally published in Clinica
The third annual EC Medical Devices Vigilance System and Postmarketing Surveillance conference will be held on January 30-31 at The Cavendish Hotel, London, UK. Aimed at a wide spectrum of device industry personnel, the event is designed to encourage greater understanding of the vigilance rules as depicted in the Directive and EC guidelines. Chaired by Roland Gerard, vice-president of RAPS, it incorporates case studies to illustrate the processes of handling reports. Further information from the Management Forum on tel: +44 (0)1483 570 099; fax: +44 (0)1483 536 424; email email@example.com www.management-forum.co.uk
You may also be interested in...
FDA Commissioner Stephen Hahn was added to the White House's pandemic task force as the outbreak grew, but he remained in a background role. That all changed the morning of 18 March, when President Trump tweeted: “I will be having a news conference today to discuss very important news from the FDA concerning the Chinese Virus!” A day later, Hahn was standing with Trump at the podium for the now-daily press briefings on Covid-19.
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.